Medications not yet evaluated by P&T are considered NON-FORMULARY . . . . . Always check 2 unique patient identifiers - NAME and DATE OF BIRTH - at every step! . . . . . Please be sure to document all clinical activities daily.
Search results for:

olsalazine

olsalazine
Drug Name Form Strength Formulary Unrestricted Formulary Restricted Non-Formulary Interchange
Dipentum CAPSULE, ORAL 250 mg    
Comments:

ORDERED FORMULATION

THERAPEUTIC INTERCHANGE

NOTES

olsalazine (Dipentum)

  • 250 mg QID  
  • 500 mg BID

mesalamine (Delzicol)

  • 400 mg QID
  • 400 mg QID

Dipentum 1 g daily interchanged to Delzicol 400 mg QID

Reviewed: 19 Jan 2017 (Pediatrics) and 24 January 2017 (Dipentum)

 

Last updated: Dec. 21, 2017






This site is intended for the staff of Huntsville Hospital.
While others may view accessible pages, Huntsville Hospital makes no warranty, express or implied,
as to the use of this information outside of Huntsville Hospital.
Please note than many documents are accessible via the provided link
only when connected to the Huntsville Hospital intranet.

Copyright © 2024 Rpharmy, LLC ­ All Rights Reserved